PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Leaf extracts and modified arginine preparations were studied for potential as a dietary supplement for prophylaxis and correction of metabolic syndrome in a rat model [PMID:34445028]
Ethanolic extract of V. corymbosum increased endurance exercise capacity and delayed muscle fatigue in mice [PMID:33170760]
Phytochemical compounds derived from blueberries exhibit antitumor properties and may serve as an alternative for the prevention of oral cancer [PMID:37375955]
In vivo and in vitro experimental results and clinical evidence demonstrate health-promoting effects, including anti-oxidant, anti-inflammatory, anti-obesity, anti-cancer, and neuroprotective activities [PMID:35344717]
Evidence summary
PubMed sources
- 1.PMID: 25416254 (2015) — Blueberry (Vaccinium corymbosum L.). · Methods in molecular biology (Clifton, N.J.)
- 2.PMID: 39166248 (2024) — Managing fruit rot diseases of Vaccinium corymbosum. · Frontiers in plant science
- 3.PMID: 34993320 (2022) — The complete chloroplast genome of highbush blueberry (Vaccinium corymbosum). · Mitochondrial DNA. Part B, Resources
- 4.PMID: 38254547 (2024) — Content of Bioactive Compounds in Highbush Blueberry Vaccinium corymbosum L. Leaves as a Potential Raw Material for Food Technology or Pharmaceutical Industry. · Foods (Basel, Switzerland)
- 5.PMID: 34445028 (2021) — Highbush Blueberry (Vaccinium corymbosum L.) Leaves Extract and Its Modified Arginine Preparation for the Management of Metabolic Syndrome-Chemical Analysis and Bioactivity in Rat Model.